Pesch, G.; Piseddu, I.; Gaertig, J.; Kramer, N.; Kramer, R.; Schulz, T. U.; Zwiebel, M.; Ledderose, S.; Retzlaff, J.; Eckstein, M. et al.; Schett, G.; Kammerbauer, C.; Schmitt, C.; Kumbrink, J.; Erdmann, M.; Kruis, W.; Dougan, M.; Mayerle, J.; French, L. E.; Vera, J.; Nordmann, T. M.; Mann, M.; Klauschen, F.; Anz, D.; Heinzerling, L.: Deep immune phenotyping reveals distinct immunopathogenesis in checkpoint inhibitor-induced colitis compared to ulcerative colitis. Cancer Immunology Research (2025)

Egea-Rodriguez, S.; Varaljai, R.; Nordmann, T. M.; Lubis, R.; Philip, M.; Rambow, F.; Roesch, A.; Flaig, M.; Horn, S.; Stoll, R. et al.; Zhao, F.; Paschen, A.; Klebl, B.; Hickson, I. D.; Schadendorf, D.; Mann, M.; Helfrich, I.: RECQL4 affects MHC class II-mediated signalling and favours an immune-evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanoma. Clinical and Translational Medicine 15 (1), e70094 (2025)

Hama, N.; Aoki, S.; Chen, C.-B.; Hasegawa, A.; Ogawa, Y.; Vocanson, M.; Asada, H.; Chu, C.-Y.; Lan, C.-C. E.; Dodiuk-Gad, R. P. et al.; Fujiyama, T.; Hsieh, T.-S.; Ito, K.; Jerschow, E.; Mizukawa, Y.; Nakajima, S.; Nakamura, K.; Nicolas, J.-F.; Satoh, T. K.; Shiohara, T.; Takahashi, H.; Tohyama, M.; Ueda, T.; Ura, K.; Watanabe, H.; Yamaguchi, Y.; Nordmann, T. M.; Chung, W.-H.; Naisbitt, D.; Pincelli, C.; Pichler, W. J.; French, L. E.; Phillips, E.; Abe, R.: Recent progress in Stevens-Johnson syndrome/toxic epidermal necrolysis: Diagnostic criteria, pathogenesis and treatment. British Journal of Dermatology 192 (1), pp. 9 - 18 (2025)